The "Ning Wang" has just officially announced an expansion of its battery swapping layout. Argus and the battery swapping company have declared the termination of their significant asset restructuring.
① Argus announced the termination of major Assets restructuring and related Trade matters; ② The main business of Argus, which involves mid to high-end dyes and textile auxiliaries, is unrelated to the symbol of the restructuring, which focuses on battery swapping Business, and there is no synergy with Argus's main business in terms of Industry or supply chain; ③ In news, Contemporary Amperex Technology officially announced today that it will increase its investment in battery swapping.
Short-term difficulties in turning around the photovoltaic film business, Fulai Ente new energy fund company will cease production | Speed Reading Notice
①The photovoltaic film is currently facing fierce price competition and production capacity adjustment. FuturEnergy has decided to suspend production and reduce losses; ②The decrease in the selling price of film products is greater than the decrease in unit cost, leading to a further decline in the gross margin of film products.
Price reduction and volume increase, Zhejiang Longsheng Group, a leading dye company, saw its net income in Q3 increase by more than three times. | Interpretations
①The company's net income for the first three quarters was 1.353 billion yuan, a year-on-year increase of 50.52%, with a 320.82% increase in net profit for the third quarter; ②Sales of dyes, additives, and intermediates by the company in the first three quarters all increased year-on-year, while dye revenue saw a slight year-on-year decline.
0.19 billion bid! Changzhou Wujin Jinkong platform acquired a listed company.
Guojing Group is a state-owned financial holding platform directly under Wujin District of Changzhou, responsible for tasks such as fund establishment, coordinated investment and recruitment, park construction and operation, and venture capital ecosystem construction; Guojing Group has established 29 collaborative sub-funds with a total scale exceeding 40 billion yuan through the development model of "fund + base + city".
The contribution of the new medical cosmetic products to performance, jiangsu wuzhong pharmaceutical development net profit in the first three quarters increased by more than three times|interpretations
①In the first three quarters, jiangsu wuzhong pharmaceutical development's net profit attributable to parent increased by 311.54% year-on-year; ②The significant increase in performance during the reporting period is mainly due to the volume of polylactic acid facial filler AestheFill; ③The decline in the pharmaceutical sector business continues to expand.
The pharmaceutical sector's gross margin is declining, can Jiangsu Wu Zhong tell a new “medical and aesthetic story”? |Annual Report Interpretation
① The 2023 report shows that Jiangsu Wuzhong has been losing money for two consecutive years, and the company's net profit also declined sharply in the first quarter of this year. ② In the medical and aesthetic business sector, on the one hand, the company introduced products from abroad, and on the other hand, entered the field of recombinant collagen through cooperative research and development. ③ It is worth paying attention to whether the AETheFill Baby Acupuncture, which was approved in January this year, can become a new performance growth point for the company in the future.